Drugs / GEMILUKAST
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01551147 | Jun 2012 → Apr 2013 | asthma | Ono Pharma USA Inc | Completed | No outcome recorded |
| Phase 2 | NCT01536041 | Mar → Nov 2012 | asthma | Ono Pharma USA Inc | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01405651 Comparator | Jul → Oct 2011 | — | Ono Pharma USA Inc | Completed | No outcome recorded |
| Phase 1 | NCT01297582 Comparator | Jan → Jun 2011 | — | Ono Pharma USA Inc | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GEMILUKAST | ChEMBL registry synonym — accepted as the source's own label CHEMBL3597634 ↗ |
| Known as | ONO-6950 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01551147 ↗ |
| Modality | Small molecule | — CHEMBL3597634 ↗ |
| Route | Oral | “single oral doses (20 and 200 mg) of ONO-6950” NCT01536041 ↗ |